Clinical Trial Update: Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX vs SYMBICORT TURBOHALER in adults with asthma; study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SPIROMAX (budesonide/formoterol)
• Symbicort Turbohaler (budesonide/formoterol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2024-03-22